Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 45

1.

Dynamics of pulse wave velocity and vascular augmentation index in association with endothelial progenitor cells in SLE.

Korsten P, Patschan D, Henze E, Niewold TB, Müller GA, Patschan S.

Lupus Sci Med. 2016 Dec 23;3(1):e000185. doi: 10.1136/lupus-2016-000185. eCollection 2016.

2.

TAC-TIC use of tacrolimus-based regimens in lupus nephritis.

Kraaij T, Bredewold OW, Trompet S, Huizinga TW, Rabelink TJ, de Craen AJ, Teng YK.

Lupus Sci Med. 2016 Dec 29;3(1):e000169. doi: 10.1136/lupus-2016-000169. eCollection 2016. Review.

3.

ECG non-specific ST-T and QTc abnormalities in patients with systemic lupus erythematosus compared with rheumatoid arthritis.

Geraldino-Pardilla L, Gartshteyn Y, Piña P, Cerrone M, Giles JT, Zartoshti A, Bathon JM, Askanase AD.

Lupus Sci Med. 2016 Dec 16;3(1):e000168. doi: 10.1136/lupus-2016-000168. eCollection 2016.

4.

Assessing QT interval in patients with autoimmune chronic inflammatory diseases: perils and pitfalls.

Lazzerini PE, Capecchi PL, Laghi-Pasini F.

Lupus Sci Med. 2016 Dec 8;3(1):e000189. doi: 10.1136/lupus-2016-000189. eCollection 2016. No abstract available.

5.

Genome-wide profiling identifies associations between lupus nephritis and differential methylation of genes regulating tissue hypoxia and type 1 interferon responses.

Mok A, Solomon O, Nayak RR, Coit P, Quach HL, Nititham J, Sawalha AH, Barcellos LF, Criswell LA, Chung SA.

Lupus Sci Med. 2016 Dec 7;3(1):e000183. doi: 10.1136/lupus-2016-000183. eCollection 2016.

6.

Age-specific and sex-specific incidence of systemic lupus erythematosus: an estimate from cross-sectional claims data of 2.3 million people in the German statutory health insurance 2002.

Brinks R, Hoyer A, Weber S, Fischer-Betz R, Sander O, Richter JG, Chehab G, Schneider M.

Lupus Sci Med. 2016 Nov 25;3(1):e000181. eCollection 2016.

7.
8.

Interferon (IFN)-λ is a potential mediator in lupus nephritis.

Zickert A, Oke V, Parodis I, Svenungsson E, Sundström Y, Gunnarsson I.

Lupus Sci Med. 2016 Nov 22;3(1):e000170. eCollection 2016.

9.

Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection.

Mackay M, Oswald M, Sanchez-Guerrero J, Lichauco J, Aranow C, Kotkin S, Korsunsky I, Gregersen PK, Diamond B.

Lupus Sci Med. 2016 Nov 10;3(1):e000159. eCollection 2016. No abstract available.

10.

Independent association of glucocorticoids with damage accrual in SLE.

Apostolopoulos D, Kandane-Rathnayake R, Raghunath S, Hoi A, Nikpour M, Morand EF.

Lupus Sci Med. 2016 Nov 22;3(1):e000157. eCollection 2016.

11.
12.

Pattern of initial clinical manifestations of systemic lupus erythematosus in a tertiary care hospital.

Batool S, Ahmad NM, Saeed MA, Farman S.

Pak J Med Sci. 2016 Sep-Oct;32(5):1066-1070.

13.

Reduction in erythrocyte-bound complement activation products and titres of anti-C1q antibodies associate with clinical improvement in systemic lupus erythematosus.

Buyon J, Furie R, Putterman C, Ramsey-Goldman R, Kalunian K, Barken D, Conklin J, Dervieux T.

Lupus Sci Med. 2016 Sep 30;3(1):e000165. eCollection 2016.

14.

Characteristics related to early secondary amenorrhoea and pregnancy among women diagnosed with systemic lupus erythematosus: an analysis using the GOAL study.

Knight JH, Howards PP, Spencer JB, Tsagaris KC, Lim SS.

Lupus Sci Med. 2016 Sep 22;3(1):e000139. eCollection 2016.

15.

Off-label use of rituximab for systemic lupus erythematosus in Europe.

Rydén-Aulin M, Boumpas D, Bultink I, Callejas Rubio JL, Caminal-Montero L, Castro A, Colodro Ruiz A, Doria A, Dörner T, Gonzalez-Echavarri C, Gremese E, Houssiau FA, Huizinga T, Inanç M, Isenberg D, Iuliano A, Jacobsen S, Jimenéz-Alonso J, Kovács L, Mariette X, Mosca M, Nived O, Oristrell J, Ramos-Casals M, Rascón J, Ruiz-Irastorza G, Sáez-Comet L, Salvador Cervelló G, Sebastiani GD, Squatrito D, Szücs G, Voskuyl A, van Vollenhoven R.

Lupus Sci Med. 2016 Sep 6;3(1):e000163. doi: 10.1136/lupus-2016-000163. eCollection 2016.

16.

Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation.

Nossent JC, Raymond WD, Eilertsen GØ.

Lupus Sci Med. 2016 Aug 15;3(1):e000162. doi: 10.1136/lupus-2016-000162. eCollection 2016.

17.

I too, am America: a review of research on systemic lupus erythematosus in African-Americans.

Williams EM, Bruner L, Adkins A, Vrana C, Logan A, Kamen D, Oates JC.

Lupus Sci Med. 2016 Aug 24;3(1):e000144. doi: 10.1136/lupus-2015-000144. eCollection 2016. Review.

18.

Assessment of direct versus indirect magnetic bead-based T-cell isolation procedures followed by magnetic bead-based DNA isolation.

Rosenbaum A, Bleck E, Schneider M, Pongratz G, Vordenbäumen S.

Lupus Sci Med. 2016 Jul 19;3(1):e000167. doi: 10.1136/lupus-2016-000167. eCollection 2016.

19.

Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.

Plantinga L, Lim SS, Bowling CB, Drenkard C.

Lupus Sci Med. 2016 Jul 19;3(1):e000161. doi: 10.1136/lupus-2016-000161. eCollection 2016.

20.

First month prednisone dose predicts prednisone burden during the following 11 months: an observational study from the RELES cohort.

Ruiz-Irastorza G, Garcia M, Espinosa G, Caminal L, Mitjavila F, González-León R, Sopeña B, Canora J, Villalba MV, Rodríguez-Carballeira M, López-Dupla JM, Callejas JL, Castro A, Tolosa C, Sánchez-García ME, Pérez-Conesa M, Navarrete-Navarrete N, Rodríguez AP, Herranz MT, Pallarés L.

Lupus Sci Med. 2016 Aug 2;3(1):e000153. doi: 10.1136/lupus-2016-000153. eCollection 2016.

Supplemental Content

Loading ...
Support Center